| Symbol | CANQF |
|---|---|
| Name | CANAQUEST MEDICAL CORPORATION |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | L5L 5S9 Canada ON 37 - 4120 Ridgeway Drive |
| Telephone | +1 416-704-3040 |
| Fax | — |
| — | |
| Website | http://canaquest.com |
| Incorporation | CA |
| Incorporated On | 2008 |
| Employees | — |
| Fiscal Year | 3/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | UNAUDITED |
| Reporting Status | Dark: Alternative Reporting Standard |
| CIK | 0001607679 |
| Description | CanaQuest Medical, an award-winning, Clinical Stage/Life-Sciences Company, is focused on drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system utilizing specific brain receptors. The drug candidate targeted for human trials is the result of R&D for cannabidiol formulations plus a drug delivery system maximizing bioavailability. The Company is working with consultants and has mapped out the regulatory pathway for a Drug Identification Number (DIN) for epilepsy, including initiating human trials, with the US - FDA and Health Canada. CanaQuest is the industry partner for research and product development with Dr. Steven Laviolette, a professor, and neuroscientist, at Western University. Additional info from OTC: |
Pink Current symbol attribute type Security_Name was changed. Previous value: -. New value: CANAQUEST MED CORP.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: CANAQUEST MED CORP.
Read more